First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.29 USD -0.3% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbvie Inc
Total Current Assets Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Total Current Assets
$33B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
6%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$16.1B
CAGR 3-Years
0%
CAGR 5-Years
-15%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$30.3B
CAGR 3-Years
13%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Moderna Inc
NASDAQ:MRNA
Total Current Assets
$10.3B
CAGR 3-Years
18%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$14.1B
CAGR 3-Years
20%
CAGR 5-Years
30%
CAGR 10-Years
24%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.5B
CAGR 3-Years
26%
CAGR 5-Years
25%
CAGR 10-Years
27%

See Also

What is Abbvie Inc's Total Current Assets?
Total Current Assets
33B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Current Assets amounts to 33B USD.

What is Abbvie Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
6%

Over the last year, the Total Current Assets growth was 16%. The average annual Total Current Assets growth rates for Abbvie Inc have been 11% over the past three years , 14% over the past five years , and 6% over the past ten years .